Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
Antineoplastic Combined Chemotherapy Protocols
Soft Tissue Neoplasms
Combination letrozole and bevacizumab was feasible with expected bevacizumab-related events of hypertension, headache, and proteinuria. Phase III proof-of-efficacy trials of endocrine therapy plus bevacizumab are in progress (Cancer and Leukemia Group B 40503).